↓ Skip to main content

Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study

Overview of attention for article published in Arthritis & Rheumatology, April 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
4 news outlets
twitter
24 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study
Published in
Arthritis & Rheumatology, April 2024
DOI 10.1002/art.42852
Pubmed ID
Authors

Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul Deodhar, Pedro M. Machado, Victoria Navarro‐Compán, Kay Geert A. Hermann, Mitsumasa Kishimoto, Eun Young Lee, Lianne S. Gensler, Uta Kiltz, Marco F. Eigenmann, Patricia Pertel, Aimee Readie, Hanno B. Richards, Brian Porter, Juergen Braun

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 17%
Other 1 17%
Student > Master 1 17%
Unknown 3 50%
Readers by discipline Count As %
Unspecified 1 17%
Neuroscience 1 17%
Medicine and Dentistry 1 17%
Unknown 3 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2024.
All research outputs
#982,223
of 25,844,183 outputs
Outputs from Arthritis & Rheumatology
#328
of 3,099 outputs
Outputs of similar age
#6,500
of 159,976 outputs
Outputs of similar age from Arthritis & Rheumatology
#3
of 39 outputs
Altmetric has tracked 25,844,183 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,099 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,976 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.